Ribozyme therapy for the treatment of proliferative skin and eye diseases
CA 2388924 A1 · Owner: Tritz, Richard · Inventors: Robbins, Joan M.; Tritz, Richard
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
As an effective therapy for proliferative skin and eye diseases such as psoriasis and proliferative diabetic retinopathy this invention provides , ribozymes and ribozyme delivery systems which cleave RNA encoding cytokines involved in inflammation, matrix metalloproteinases a cyclin, a cell-cycle , dependent kinase a growth factor, or a reductase.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 26, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 26, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 26, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.